U.S. Markets close in 1 hr 59 mins
  • S&P 500

    3,642.94
    +13.29 (+0.37%)
     
  • Dow 30

    29,928.55
    +56.08 (+0.19%)
     
  • Nasdaq

    12,229.11
    +134.71 (+1.11%)
     
  • Russell 2000

    1,846.05
    +1.02 (+0.06%)
     
  • Crude Oil

    45.30
    -0.41 (-0.90%)
     
  • Gold

    1,785.40
    -25.80 (-1.42%)
     
  • Silver

    22.75
    -0.70 (-2.99%)
     
  • EUR/USD

    1.1950
    +0.0037 (+0.3107%)
     
  • 10-Yr Bond

    0.8550
    -0.0230 (-2.62%)
     
  • Vix

    20.83
    -0.42 (-1.98%)
     
  • GBP/USD

    1.3345
    -0.0012 (-0.0881%)
     
  • USD/JPY

    103.9980
    -0.2520 (-0.2417%)
     
  • BTC-USD

    16,560.78
    -373.60 (-2.21%)
     
  • CMC Crypto 200

    323.93
    -13.57 (-4.02%)
     
  • FTSE 100

    6,359.29
    -3.64 (-0.06%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Collegium to Present at Upcoming Investor Conferences

STOUGHTON, Mass., April 01, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will present at the following investor conferences in April:

  • The H.C. Wainwright Global Life Sciences Conference on Monday, April 8th at 11:10 a.m. GMT in London

  • The Needham Healthcare Conference on Wednesday, April 10th at 2:50 p.m. EDT in New York City

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com